Tag: Why We Invested

  • September 21, 2022
    By Matt Fates, Partner at Innospark Ventures At any given time, there are roughly 400,000 clinical trials occurring globally. In…
  • July 7, 2022
    As skilled and advanced as the $2T pharma industry is in many regards, there are still key areas where it…